Semaglutide-related weight loss can temporarily lower some values, making pre-donation assessment critical for both donor safety and plasma quality assurance
If nausea makes solid food difficult, protein shakes become essential
The importance of adhering to Wegovys dosing schedule Wegovy, a glucagon-like peptide-1 receptor agonist, supports weight loss by mimicking the hormone GLP-1, slowing digestion, and reducing appetite
This information may help provide context for a provider conversation about whether GLP-1 treatment's potential neuropsychiatric effects are more likely to be relevant to your specific genetic profilesupporting truly personalized decision-making
It stimulates glucose uptake, increases fat metabolism, and boosts mitochondrial function
Side Effects & Tolerability in a Southwest Climate Both medications can cause transient gastrointestinal effects-nausea, bloating, and occasional diarrhea or constipation